Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced the ...

Abnormal cells can clog blood vessels, leading to severe pain episodes and restricting oxygen delivery to vital organs ...

We can do better. We can build a system that provides coordinated high-quality care to every patient who needs it.

Read about the opening of London's newest blood donation centre, aiming to increase the number of Black heritage donors.

WINSTON-SALEM, N.C. — Emory Moore, a 12-year-old treated at Brenner Children’s Hospital for sickle cell disease, received a ...

Results showed that sickle cell patients suffer from premature brain aging, and that the aging affects their performance on ...

IMMvention Therapeutix, Inc., a Durham early-stage biotechnology company focused on discovering and developing human ...

Rigel Pharmaceuticals has enrolled the first subject in a Phase I trial of its oral spleen tyrosine kinase (SYK) inhibitor, ...

Statistics from the district health department indicate that in 2023, suspected cases of sickle cells stood at 1,456 and in ...

Madhya Pradesh has achieved 100 per cent target by screening 90,98,902 persons for the sickle cell disease so far, a ...

Novo Nordisk is opening a new front in its fight against sickle cell disease, inking a deal with IMMvention Therapeutix to co ...